Table 1.

Correlates of obtaining NAF

PredictorNAF not obtained (n = 126)NAF obtained (n = 45)P
Menopausal status, n (%)
    Premenopausal71 (76.3)22 (23.7)0.49
    Postmenopausal55 (70.5)23 (29.5)
BRCA1/2 mutation status, n (%)
    Noncarrier (excluding 2 untested)13 (56.5)10 (43.5)0.06 among all 3 categories
    Carrier BRCA167 (74.4)23 (25.6)0.04 carriers vs noncarriers
    Carrier BRCA246 (82.1)10 (17.9)0.31 among carriers only
Parity, n (%)
    Nulliparous56 (80.0)14 (20.0)0.16
    Parous (≥1 births)70 (69.3)31 (30.7)
Breast-feeding, n (%)
    Never breast-fed65 (77.4)19 (22.6)0.30
    Ever breast-fed61 (70.1)26 (29.9)
Personal history of breast or ovarian cancer, n (%)
    No106 (71.6)42 (28.4)0.14
    Yes20 (87.0)3 (13.0)
Prior ovarian surgery, n (%)
    Never, unilateral oophorectomy76 (73.8)27 (26.2)1.00
    Bilateral oophorectomy50 (73.5)18 (26.5)
Prior breast surgery, n (%)
    None105 (71.9)41 (28.1)0.32
    Mastectomy or lumpectomy21 (84.0)4 (16.0)
Prior chemotherapy, n (%)
    No111 (72.1)43 (27.9)0.24
    Yes15 (88.2)2 (11.8)
Prior radiation, n (%)
    No113 (72.0)44 (28.0)0.12
    Yes13 (92.9)1 (7.1)
Current MHT use, n (%)
    No114 (74.5)39 (25.5)0.57
    Yes12 (66.7)6 (33.3)
Current OCP use, n (%)
    No108 (85.7)39 (86.7)0.87
    Yes18 (14.3)6 (13.3)
Current SERM use, n (%)
    No113 (71.5)45 (28.5)0.02
    Yes13 (100.0)0
Age, mean (y)39.542.50.04
Body mass index, mean (kg/m2)26.027.20.30